Reversal of multidrug resistance of breast carcinoma by antisense oligodeoxynucleotide combined with nanometer particle

彭志平; 李少林; 文明; 蒋明东; 段红; 王树斌

您当前的位置：

首页 >

文章列表页 >

Reversal of multidrug resistance of breast carcinoma by antisense oligodeoxynucleotide combined with nanometer particle

更新时间：2026-01-09

- Reversal of multidrug resistance of breast carcinoma by antisense oligodeoxynucleotide combined with nanometer particle
- Journal of Army Medical University Vol. 31, Issue 6, Pages: 498-501(2009)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC： R394-33;R394.6;R737.9
- Published：2009
- 稿件说明：
移动端阅览
彭志平,李少林,文明,蒋明东,段红,王树斌.纳米微粒介导反义寡脱氧核苷酸逆转乳腺癌细胞多药耐药的实验研究[J].陆军军医大学学报(原第三军医大学学报),2009,31(06):498-501.

　PENG Zhi-ping,LI Shao-lin,WEN Ming,JIANG Ming-dong,Duan Hong,WANG Shu-bin.Reversal of multidrug resistance of breast carcinoma by antisense oligodeoxynucleotide combined with nanometer particle[J].J Amry Med Univ (J Third Mil Med Univ),2009,31(06):498-501.
彭志平,李少林,文明,蒋明东,段红,王树斌.纳米微粒介导反义寡脱氧核苷酸逆转乳腺癌细胞多药耐药的实验研究[J].陆军军医大学学报(原第三军医大学学报),2009,31(06):498-501. DOI：

　PENG Zhi-ping,LI Shao-lin,WEN Ming,JIANG Ming-dong,Duan Hong,WANG Shu-bin.Reversal of multidrug resistance of breast carcinoma by antisense oligodeoxynucleotide combined with nanometer particle[J].J Amry Med Univ (J Third Mil Med Univ),2009,31(06):498-501. DOI：

摘要

目的探讨纳米微粒介导耐药基因mdr-1、mrp反义寡脱氧核苷酸（antisense oligodeoxynucleotide

ASODN）转染对多药耐药乳腺癌MCF-7/ADR细胞的影响。方法采用纳米微粒介导mdr-1、mrp-ASODN转染耐药细胞株MCF-7/ADR，RT-PCR、Western blot检测转染48 h后细胞耐药基因mdr-1、mrp的表达；MTT法检测经转染后MCF-7/ADR细胞对阿霉素（ADR）、表柔比星（epirubicin）、5-氟脲嘧啶（5-FU）和紫杉醇（paclitaxel）的敏感性。结果纳米微粒介导mdr-1、mrp ASODN转染48 h后，MCF-7/ADR细胞的mdr-1、mrp在mRNA和蛋白质表达水平上均显著降低（P0.05）；细胞对ADR、表柔比星、5-氟脲嘧啶和紫杉醇的耐药指数均显著降低（P0.05）。结论耐药基因反义寡脱氧核苷酸能在体外抑制耐药基因的表达，从而提高细胞的药物敏感性；纳米微粒具有较好的体外介导反义寡脱氧核苷酸转染效果。

Abstract

Objective To explore the reversing effect of antisense oligodeoxynucleotide (ASOND) mediated by nanometer particle against multidrug resistance genes mdr-1 and mrp on the multidrug resistance of breast cancer cell line MCF-7/ADR. Methods ASOND of mdr-1 and ASODN of mrp were respectively transfected into MCF-7/ADR cells by nanometer particle. Their sense oligodeoxynucleotides were also transduced to serve as control. The changes of mdr-1 and mrp expressions were detected by reverse transcription-polymerase chain reaction (RT-PCR) and Western blotting in 48 h after transfection. MTT assay were performed to evaluate the sensibility of the transfected cells to adriamycin

epirubicin

5-fluorouracil and paclitaxel respectively. Results After 48 hours’ exposure to mdr-1-ASODN or mrp-ASODN mediated by nanometer particle

MCF-7/ADR cells significantly reduced the expressions of mdr-1 and mrp in mRNA and protein levels (P0.05)

and enhanced drug sensitivity to adriamycin

epirubicin

5-fluorouracil and paclitaxel respectively (P0.05). Conclusion ASOND enhances the drug sensitivity of breast cancer cell line MCF-7/ADR by inhibiting the expressions of drug resistance genes. Nanometer particle is a valid tool to mediate ASOND in vitro.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

A novel estrogen receptor expression stratification (low/moderate/high) based on Chinese population provides more accurate prognosis prediction for HR⁺/HER2^- early breast cancer patients

Downregulating RRM2B expression to increase radiation sensitivity of breast cancer cells

Characteristics of body image and their relationship with perceived stress, self-compassion and implicit attitudes in female breast cancer patients

Prognostic factors for breast cancer brain metastasis and primary construction of a prediction model

LINC00294 promotes proliferation, invasion, and migration of breast cancer cells via AKT/mTOR/HIF-1α pathway

Related Author

WANG Chengfang

ZHOU Yuqin

ZHANG Yanling

QI Xiaowei

ZHANG Yi

李安琪

孙海燕

祁孟瑶

Related Institution

Department of Breast and Thyroid Surgery， First Affiliated Hospital， Army Medical University （Third Military Medical University）

Faculty of Pharmacology， College of Pharmacy

Chongqing Key Research Laboratory for Drug Metabolism， Chongqing Medical University

Department of Pharmacy， the First Affiliated Hospital of Chongqing Medical University

Department of Pharmacy， Women and Children's Hospital of Chongqing Medical University

⁰